Learn more in the 2025 Employer Health Benefits Survey: GLP-1 weight-loss drugs coverage by large employers Coverage of GLP-1 weight-loss drugs is growing among the largest employers (5000+ workers), now at 43%
We consult and facilitate patients, hospitals, clinicians and researchers in accessing products through reliable sources, which are not available or approved in their home country
Live provider consultations
What To Avoid When Taking Glutathione IV
Reproductive and hormonal effects: Research indicates that GLP-1 therapy can reduce total and free testosterone levels, likely secondary to improved insulin sensitivity and weight loss
Because the schedule is weekly rather than daily, it is easy for people to occasionally forget a dose especially during travel, busy weeks or schedule changes